1-8 of 8
Miriam B. Garcia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of Pedi-Crib: Mini-Hyper-CVD with Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric Patients with B-Cell Lineage Acute Lymphocytic Leukemia

David McCall, Amber Gibson, Miriam B. Garcia, Cesar Nunez, Michael E. Roth, Branko Cuglievan
Journal: Blood
Blood (2024) 144 (Supplement 1): 1431.1.
https://doi.org/10.1182/blood-2024-212144
Published: 2024
Journal Articles

A Phase I Study Investigating the Combination of the Ziftomenib, Venetoclax and Azacitidine (ZiVA) in Pediatric Relapsed and Refractory Acute Leukemias

David McCall, Branko Cuglievan, Amber Gibson, Miriam B. Garcia, Michael E. Roth, Cesar Nunez
Journal: Blood
Blood (2024) 144 (Supplement 1): 1504.4.
https://doi.org/10.1182/blood-2024-208146
Published: 2024
Journal Articles

Multimodal Spatial Profiling in Acute Myeloid Leukemia

Christopher P. Ly, Ivo Veletic, Christopher D. Pacheco, Enes Dasdemir, Fatima Z Jelloul, Sammy Ferri-Borgogno, Akshay Basi, Javier A. Gomez, Jessica Lynn Root, Patrick K. Reville, Andres E Quesada, Carlos E. Bueso-Ramos, Miriam B. Garcia, Jared K. Burks, Hussein A. Abbas
Journal: Blood
Blood (2024) 144 (Supplement 1): 2681.
https://doi.org/10.1182/blood-2024-203816
Published: 2024
Journal Articles

FLAG IDA Venetoclax in Newly Diagnosed Pediatric and AYA Patients with AML

Reeja Raj, Samanta Catueno, Amber Gibson, David McCall, Miriam B. Garcia, Cesar Nunez, Michael E. Roth, Koji Sasaki, Priti Tewari, Branko Cuglievan, Courtney D. DiNardo
Journal: Blood
Blood (2024) 144 (Supplement 1): 2906.
https://doi.org/10.1182/blood-2024-211771
Published: 2024
Journal Articles

Targeted Protein Degradation for c-MYC Overcomes Therapy Resistance in T-Cell Acute Lymphoblastic Leukemias

Faryal Munir, Shayaun Khazaei, Phoebe H. Calkins, Darah Scruggs, Hideaki Mizuno, Lauren B. Ostermann, Branko Cuglievan, Miriam B. Garcia, Dong Chen, Youzhi Tong, Zhihua Ren, Michael Andreeff, Yuki Nishida
Journal: Blood
Blood (2023) 142 (Supplement 1): 1447.
https://doi.org/10.1182/blood-2023-187496
Published: 2023
Journal Articles

IFNγ Signaling in Acute Myeloid Leukemia Mediates Immunomodulation and Reveals Therapeutic Strategies

Bofei Wang, Patrick K Reville, Fatima Z Jelloul, Poonam N Desai, Pamella Borges, Christopher Ly, Ivo Veletic, Enes Dasdemir, Jared K. Burks, Guilin Tang, Shengnan Guo, Nicole Vaugh, Natalia Baran, Qing Deng, Jairo Matthews, Preethi Gunaratne, Dinler A Antunes, Suhendan Ekmekcioglu, Koji Sasaki, Miriam B. Garcia, Branko Cuglievan, Dapeng Hao, Naval Daver, Michael R. Green, Marina Y. Konopleva, Andy Futreal, Sean M. Post, Hussein A Abbas
Journal: Blood
Blood (2023) 142 (Supplement 1): 2796.
https://doi.org/10.1182/blood-2023-175010
Published: 2023
Journal Articles

Early Results of the Phase I/II Study Investigating the All-Oral Combination of the Menin Inhibitor Revumenib (SNDX-5613) with Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

Ghayas C. Issa, Branko Cuglievan, Courtney D. DiNardo, Nicholas J. Short, David McCall, Amber Gibson, Cesar Nunez, Miriam B. Garcia, Michael Roth, Aram Bidikian, Allison Pike, Sheila Tan, Brianna Kammerer, Musa Yilmaz, Tapan M. Kadia, Naveen Pemmaraju, Maro Ohanian, Naval Daver, Elias Jabbour, Gautam Borthakur, Farhad Ravandi, Guillermo Garcia-Manero, Michael Andreeff, Hagop M. Kantarjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 58.
https://doi.org/10.1182/blood-2023-182337
Published: 2023
Journal Articles

Frontline Venetoclax Therapy for 18-Year-Old Male with Ataxia Telangiectasia and Early T-Cell Precursor Acute Lymphoblastic Leukemia

Shaikha Alqahtani, Ramya Ramakrishnan, Cesar Nunez, David McCall, Miriam B. Garcia, Branko Cuglievan, Amber Gibson
Journal: Blood
Blood (2023) 142 (Supplement 1): 5819.
https://doi.org/10.1182/blood-2023-185261
Published: 2023